You are here
- Home
- topic
- BMJ Open Respiratory Research
- BMJ Open Respiratory Research
- Interstitial lung disease
Interstitial lung disease
- Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trialsLisa Lancaster, Bruno Crestani, Paul Hernandez, Yoshikazu Inoue, Daniel Wachtlin, Lazaro Loaiza, Manuel Quaresma, Susanne Stowasser, Luca RicheldiBMJ Open Respiratory Research Mar 2019, 6 (1) e000397; DOI: 10.1136/bmjresp-2018-000397
- The King’s Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important differenceAish Sinha, Amit Suresh Patel, Richard J Siegert, Sabrina Bajwah, Toby M Maher, Elizabeth A Renzoni, Athol U Wells, Irene J Higginson, Surinder S BirringBMJ Open Respiratory Research Feb 2019, 6 (1) e000363; DOI: 10.1136/bmjresp-2018-000363
- Sarcoidosis in the UK: insights from British Thoracic Society registry dataMuhunthan Thillai, William Chang, Nazia Chaudhuri, Ian Forrest, Ling-Pei Ho, Sarah Lines, Toby M Maher, Lisa G Spencer, Monica Spiteri, Robina CokerBMJ Open Respiratory Research Feb 2019, 6 (1) e000357; DOI: 10.1136/bmjresp-2018-000357
- First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiativeNynke A Kampstra, Jan C Grutters, Frouke T van Beek, Daniel A Culver, Robert P Baughman, Elisabetta A Renzoni, Wim Wuyts, Vaslis Kouranos, Marlies S Wijsenbeek, Douwe H Biesma, Philip J van der Wees, Paul B van der NatBMJ Open Respiratory Research Feb 2019, 6 (1) e000394; DOI: 10.1136/bmjresp-2018-000394
- Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needsShaney L Barratt, Michelle Morales, Toby Spiers, Khaled Al Jboor, Heather Lamb, Sarah Mulholland, Adrienne Edwards, Rachel Gunary, Patricia Meek, Nikki Jordan, Charles Sharp, Clare Kendall, Huzaifa I AdamaliBMJ Open Respiratory Research Dec 2018, 5 (1) e000360; DOI: 10.1136/bmjresp-2018-000360
- Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registryWim A Wuyts, Caroline Dahlqvist, Hans Slabbynck, Marc Schlesser, Natacha Gusbin, Christophe Compere, Sofie Maddens, Klaus-Uwe Kirchgaessler, Karen Bartley, Benjamin BondueBMJ Open Respiratory Research Nov 2018, 5 (1) e000331; DOI: 10.1136/bmjresp-2018-000331
- Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective studyMasatoshi Yamazoe, Hiromi TomiokaBMJ Open Respiratory Research Oct 2018, 5 (1) e000342; DOI: 10.1136/bmjresp-2018-000342
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trialToby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Vincent CottinBMJ Open Respiratory Research Sep 2018, 5 (1) e000289; DOI: 10.1136/bmjresp-2018-000289
- Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trialToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, Eric S White, Vincent Cottin, Imre Noth, Moisés Selman, Zuzana Blahova, Daniel Wachtlin, Claudia Diefenbach, R Gisli JenkinsBMJ Open Respiratory Research Aug 2018, 5 (1) e000325; DOI: 10.1136/bmjresp-2018-000325
- Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trialsSteven D Nathan, Lisa H Lancaster, Carlo Albera, Marilyn K Glassberg, Jeffrey J Swigris, Frank Gilberg, Klaus-Uwe Kirchgaessler, Susan L Limb, Ute Petzinger, Paul W NobleBMJ Open Respiratory Research Aug 2018, 5 (1) e000323; DOI: 10.1136/bmjresp-2018-000323
Pages
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)